Table 16: Patient Characteristics: Contact Laser Vaporization Versus TURP.
| Study, Year | Patients, No (Treatment, control) | Inclusion criteria | Prostate size Mean (SD), mL | Mean follow-up (Years) | No available for follow-up |
|---|---|---|---|---|---|
| Tuhkanen et al. 2003 (70) | 52 (26, 26) |
Patients with symptomatic BPH with prostate size <40 mL; BOO confirmed by pressure-flow studies | CLV: 30 TURP: 28 NS |
4 | CLV: 22 TURP: 20 |
| Van Melick et al. 2003 (54) 3-arm study |
95 (45, 50) Third arm received TUVP, n=46 |
Patients older than 45 years of age and LUTS due to BPH (Schafer’s obstruction grade ≥2) and prostate volume 20–65 cm3 | CLV: 37 (11) TURP: 37 (11) |
CLV 1–4 year: 2.6 (0.(0 4–7 years 5.5 (0.7) TURP 1–4 years: 2.7 (0.8) 4–7 years: 5.7 (0.8) |
1 year CLV: 37 TURP: 41 1–4 years CLV: 10 TURP: 15 4–7 years CLV: 27 TURP: 30 |
| Keoghane et al. 2000 (34) | 148 (72, 76) |
Patients with BPH presenting for TURP | NR | 3 |
1 year CLV: 58 TURP: 64 2 years CLV:47 TURP: 53 3 years CLV: 43 TURP: 44 |
BBO refers to bladder outlet obstruction; BPH, benign prostatic hyperplasia; CLV, contact laser vaporization; LUTS, lower urinary tract symptoms; NR, not reported; SD, standard deviation; TURP, transurethral resection of the prostate; TUVP, Transurethral electrovaporization of the prostate